-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Vera Therapeutics, Raises Price Target to $70

Benzinga·07/07/2026 18:54:14
Listen to the news
B of A Securities analyst Dina Ramadane maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $65 to $70.